AZENTA, INC. (AZTA) FY2026 Q3 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
AZENTA, INC. (AZTA) FY2026 Q3 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 1,876,211,000 US dollars
- Current assets
- 681,351,000 US dollars
- Non-current assets
- 1,194,860,000 US dollars
- Liabilities
- 366,082,000 US dollars
- Current liabilities
- 272,574,000 US dollars
- Non-current liabilities
- 93,508,000 US dollars
- Equity
- 1,510,129,000 US dollars
- Cash and cash equivalents
- 189,654,000 US dollars
- Accounts receivable, net of allowance for expected credit losses ($3,842 and $4,649, respectively)
- 143,675,000 US dollars
- Short-term marketable securities
- 136,143,000 US dollars
- Inventories
- 79,082,000 US dollars
- Current assets held for sale
- 71,387,000 US dollars
- Prepaid expenses and other current assets
- 53,150,000 US dollars
- Refundable income taxes
- 5,846,000 US dollars
- Short-term restricted cash
- 2,414,000 US dollars
- Goodwill
- 547,457,000 US dollars
- Long-term marketable securities
- 196,087,000 US dollars
- Property, plant and equipment, net
- 172,427,000 US dollars
- Intangible assets, net
- 85,688,000 US dollars
- Noncurrent assets held for sale
- 76,689,000 US dollars
- Operating lease right-of-use assets
- 61,421,000 US dollars
- Long-term income taxes receivable
- 45,600,000 US dollars
- Other assets
- 8,997,000 US dollars
- Long-term deferred tax assets
- 494,000 US dollars
- Accounts payable
- 39,381,000 US dollars
- Deferred revenue
- 36,041,000 US dollars
- Customer deposits
- 35,355,000 US dollars
- Accrued expenses and other current liabilities
- 34,249,000 US dollars
- Accrued compensation and benefits
- 30,965,000 US dollars
- Current liabilities held for sale
- 29,326,000 US dollars
- Derivative liability
- 28,435,000 US dollars
- Deposit received for the sale of B Medical Systems business
- 28,000,000 US dollars
- Accrued income taxes payable
- 6,775,000 US dollars
- Accrued warranty and retrofit costs
- 4,047,000 US dollars
- Long-term operating lease liabilities
- 53,967,000 US dollars
- Long-term deferred tax liabilities
- 15,836,000 US dollars
- Noncurrent liabilities held for sale
- 12,980,000 US dollars
- Other long-term liabilities
- 10,725,000 US dollars
- Retained earnings
- 1,246,182,000 US dollars
- Additional paid-in capital
- 493,071,000 US dollars
- Common stock, $0.01 par value - 125,000,000 shares authorized, 57,226,616 shares issued and 43,764,747 shares outstanding at June 30, 2026; 59,320,848 shares issued and 45,858,979 shares outstanding at September 30, 2025
- 572,000 US dollars
- Preferred stock, $0.01 par value - 1,000,000 shares authorized, no shares issued or outstanding
- 0 US dollars
- Treasury stock, at cost - 13,461,869 shares at June 30, 2026 and September 30, 2025
- negative 200,956,000 US dollars
- Accumulated other comprehensive loss
- negative 28,740,000 US dollars
- Gross equity (calculated)
- 1,739,825,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
